Cargando…
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
BACKGROUND: Germline mutations in the BRCA1 and BRCA2 genes predispose carriers to breast and ovarian cancer, and there remains a need to identify the specific genomic mechanisms by which cancer evolves in these patients. Here we present a systematic genomic analysis of breast tumors with BRCA1 and...
Autores principales: | Lal, Avantika, Ramazzotti, Daniele, Weng, Ziming, Liu, Keli, Ford, James M., Sidow, Arend |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558765/ https://www.ncbi.nlm.nih.gov/pubmed/31182087 http://dx.doi.org/10.1186/s12920-019-0545-0 |
Ejemplares similares
-
De novo mutational signature discovery in tumor genomes using SparseSignatures
por: Lal, Avantika, et al.
Publicado: (2021) -
Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival
por: Ramazzotti, Daniele, et al.
Publicado: (2018) -
SparseSignatures: An R package using LASSO-regularized non-negative matrix factorization to identify mutational signatures from human tumor samples
por: Mella, Lorenzo, et al.
Publicado: (2022) -
A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer
por: Karami, Fatemeh, et al.
Publicado: (2013) -
Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil
por: Carraro, Dirce Maria, et al.
Publicado: (2013)